Chemotherapeutic induction of Egr-1 promoter activity

Details for Australian Patent Application No. 2002303247 (hide)

International Classifications

Event Publications

12 December 2002 Complete Application Filed

Priority application(s): 60/282,040 06.04.01 US

10 April 2003 Application Open to Public Inspection

Published as AU-B-2002303247

27 January 2005 Amendment Made

The nature of the amendment is: Add the name of the coapplicant Dana-Farber Cancer Institute

24 March 2005 Application Accepted

Published as AU-B-2002303247

21 July 2005 Standard Patent Sealed

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.